[
  {
    "variant_string_id": "LRRK2 Y169H",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "LRRK2 mutations are linked to Parkinson’s disease and are believed to impact kinase activity, disrupting cellular processes such as autophagy and protein degradation.",
        "judgment": "Yes",
        "reasoning": "The paper directly states the link between LRRK2 mutations and Parkinson's disease and the suspected role of kinase activity disruption."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Kinase activity assays are frequently utilized to assess the impact of LRRK2 mutations on kinase function, which is a core pathological mechanism.",
        "judgment": "Yes",
        "reasoning": "The kinase activity assay directly models the suspected disease mechanism of kinase activity disruption.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The study included a wild-type LRRK2 protein control and a kinase-dead mutant as a negative control.  Experiments were repeated three times independently.",
        "judgment": "Yes",
        "reasoning": "Both wild-type and kinase-dead controls were used, and the experiment was repeated multiple times."
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The study used a pathogenic LRRK2 mutation (R148H) as a positive control for enhanced kinase activity.",
        "judgment": "Yes",
        "reasoning": "A known pathogenic variant (R148H) was used as a positive control."
      },
      {
        "step_name": "Step 4a: Statistical Analyses",
        "extracted_paper_info": "Statistical significance (p < 0.05) was determined using Student’s t-test to compare kinase activity between Y169H mutant and wild-type LRRK2.",
        "judgment": "Yes",
        "reasoning": "The paper describes statistical analysis using a t-test and reports a p-value."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The Y169H variant demonstrates increased kinase activity compared to wild-type LRRK2, statistically significant and supported by the use of appropriate controls, including a known pathogenic variant. This strengthens the likelihood of pathogenicity."
  }
]